Metastatic squamous cell carcinoma of the anus: time for a shift in the treatment paradigm?

First Case of the Cervical Lymph Node as the Only Site of Metastasis from Anal Cancer. Cureus (2017) 0.75

Radiotherapy plus cetuximab for squamous-cell carcinoma of the head and neck. N Engl J Med (2006) 25.67

Capecitabine and oxaliplatin for advanced esophagogastric cancer. N Engl J Med (2008) 12.97

Epidermoid anal cancer: results from the UKCCCR randomised trial of radiotherapy alone versus radiotherapy, 5-fluorouracil, and mitomycin. UKCCCR Anal Cancer Trial Working Party. UK Co-ordinating Committee on Cancer Research. Lancet (1996) 5.65

Concomitant radiotherapy and chemotherapy is superior to radiotherapy alone in the treatment of locally advanced anal cancer: results of a phase III randomized trial of the European Organization for Research and Treatment of Cancer Radiotherapy and Gastrointestinal Cooperative Groups. J Clin Oncol (1997) 5.18

Human papillomavirus, smoking, and sexual practices in the etiology of anal cancer. Cancer (2004) 4.04

Anal cancer incidence and survival: the surveillance, epidemiology, and end results experience, 1973-2000. Cancer (2004) 3.40

Chemoradiation for the treatment of epidermoid anal cancer: 13-year follow-up of the first randomised UKCCCR Anal Cancer Trial (ACT I). Br J Cancer (2010) 1.57

Anal cancers among HIV-infected persons: HAART is not slowing rising incidence. AIDS (2010) 1.39

Definitive irradiation and chemotherapy for radiosensitization in management of anal carcinoma: interim report on Radiation Therapy Oncology Group study no. 8314. J Natl Cancer Inst (1989) 1.34

Cetuximab-based treatment of metastatic anal cancer: correlation of response with KRAS mutational status. Oncology (2009) 1.27

Growth factor receptor expression in anal squamous lesions: modifications associated with oncogenic human papillomavirus and human immunodeficiency virus. Hum Pathol (2009) 1.13

[5-fluorouracile and cisplatinum combination chemotherapy for metastatic squamous-cell anal cancer]. Bull Cancer (1999) 1.10

Prognostic factors derived from a prospective database dictate clinical biology of anal cancer: the intergroup trial (RTOG 98-11). Cancer (2010) 1.09

Combination of cisplatin plus fluoropyrimidine chemotherapy effective against liver metastases from carcinoma of the anal canal. Am J Med (1989) 1.09

Patient preference for oral or intravenous chemotherapy: a randomised cross-over trial comparing capecitabine and Nordic fluorouracil/leucovorin in patients with colorectal cancer. Eur J Cancer (2006) 1.07

Liver-directed surgery for metastatic squamous cell carcinoma to the liver: results of a multi-center analysis. Ann Surg Oncol (2007) 1.07

Evidence of clinical activity for cetuximab combined with irinotecan in a patient with refractory anal canal squamous-cell carcinoma: report of a case. Dis Colon Rectum (2007) 1.05

Phase II study of the combination of cetuximab and weekly paclitaxel in the first-line treatment of patients with recurrent and/or metastatic squamous cell carcinoma of head and neck. Ann Oncol (2011) 1.02

Epidermal growth factor receptor expression in anal canal carcinoma. Am J Clin Pathol (2005) 1.01

Molecular biomarkers correlate with disease-free survival in patients with anal canal carcinoma treated with chemoradiation. Dig Dis Sci (2009) 1.00

Phase II study of paclitaxel, carboplatin, and cetuximab as first line treatment, for patients with advanced non-small cell lung cancer (NSCLC): results of OPN-017. J Thorac Oncol (2008) 0.92

Combined modality therapy for HIV-infected patients with squamous cell carcinoma of the anus: outcomes and toxicities. Int J Radiat Oncol Biol Phys (2006) 0.91

Cisplatin and 5-fluorouracil as salvage therapy for recurrent metastatic squamous cell carcinoma of the anal canal. Am J Clin Oncol (1993) 0.91

Prognostic biomarkers in squamous cell carcinoma of the anus: a systematic review. Br J Cancer (2010) 0.90

Expression of epidermal growth factor receptor in squamous cell carcinomas of the anal canal is independent of gene amplification. Mod Pathol (2006) 0.90

Phase II study of mitomycin-C, adriamycin, cisplatin (MAP) and Bleomycin-CCNU in patients with advanced cancer of the anal canal: An eastern cooperative oncology group study E7282. Invest New Drugs (2006) 0.89

Anal carcinoma: histology, staging, epidemiology, treatment. Curr Opin Oncol (2000) 0.88

Response of metastatic anal carcinoma to single agent carboplatin. Clin Oncol (R Coll Radiol) (1993) 0.87

The Role of EGFR Inhibitors in the Treatment of Metastatic Anal Canal Carcinoma: A Case Series. J Oncol (2011) 0.86

Effective treatment of anal cancer in the elderly with low-dose chemoradiotherapy. Br J Cancer (2005) 0.84

Response of metastatic epidermoid anal cancer to single agent irinotecan: a case report. Tumori (2001) 0.83

Reduced expression of p21WAF1 is an indicator of malignant behaviour in anal carcinomas. Histopathology (2001) 0.83

A regimen of taxol, Ifosfamide, and platinum for recurrent advanced squamous cell cancer of the anal canal. Chemother Res Pract (2011) 0.83

Prognostic role of p53 protein expression in epidermoid carcinoma of the anal canal. Int J Radiat Oncol Biol Phys (1999) 0.82

Paclitaxel, carboplatin, and long-term continuous infusion of 5-fluorouracil in the treatment of advanced squamous and other selected carcinomas: results of a Phase II trial. Cancer (2001) 0.82

Prognostic factors in anal squamous carcinoma: a multivariate analysis of clinical, pathological and flow cytometric parameters in 235 cases. Histopathology (1990) 0.81

Phase II study of combination bleomycin, vincristine and high-dose methotrexate (BOM) with leucovorin rescue in advanced squamous cell carcinoma of the anal canal. Cancer Chemother Pharmacol (1985) 0.81

Overexpression of p53 protein and outcome of patients treated with chemoradiation for carcinoma of the anal canal: a report of randomized trial RTOG 87-04. Radiation Therapy Oncology Group. Cancer (1999) 0.80

Molecular characterization and response to cetuximab in a patient with refractory squamous cell anal carcinoma. Tumori (2010) 0.80

Cisplatin plus 5-fluorouracil in the treatment of metastatic anal squamous cell carcinoma: a report of two cases. Cancer Treat Rep (1986) 0.79

Metastatic cloacogenic carcinoma of the anus: sequential responses to adriamycin and cis-dichlorodiammineplatinum(II). Cancer Treat Rep (1978) 0.79

Recurrent epidermoid cancer of the anus. Cancer (1986) 0.77

Response of metastatic cloacogenic carcinoma to treatment with semustine. Cancer (1981) 0.77

Capecitabine and oxaliplatin for advanced esophagogastric cancer. N Engl J Med (2008) 12.97

Thromboembolism in patients with advanced gastroesophageal cancer treated with anthracycline, platinum, and fluoropyrimidine combination chemotherapy: a report from the UK National Cancer Research Institute Upper Gastrointestinal Clinical Studies Group. J Clin Oncol (2009) 1.45

Why faculty must promote their own self-care. Acad Med (2013) 1.06

The genomic landscape of oesophagogastric junctional adenocarcinoma. J Pathol (2013) 0.95

Docetaxel and irinotecan as second-line therapy for advanced oesophagogastric cancer. Eur J Cancer (2011) 0.91

Perioperative chemotherapy with or without bevacizumab in patients with metastatic colorectal cancer undergoing liver resection. Clin Colorectal Cancer (2012) 0.83

Peri-operative chemotherapy in the management of resectable colorectal cancer pulmonary metastases. BMC Cancer (2012) 0.83

Selecting patients with locally advanced rectal cancer for neoadjuvant treatment strategies. Oncologist (2013) 0.81

Metastatic breast cancer presenting as a primary hindgut neuroendocrine tumour. Anticancer Res (2010) 0.78

Trastuzumab for gastric cancer treatment. Lancet (2010) 0.77

Chemotherapy for operable gastric cancer: current perspectives. Indian J Surg Oncol (2012) 0.76